tradingkey.logo
tradingkey.logo
Search

PMV Pharmaceuticals Inc

PMVP
Add to Watchlist
1.240USD
-0.090-6.77%
Close 07-24 16:00ETQuotes delayed by 15 min
66.13MMarket Cap
LossP/E TTM

PMVP Income Statement

You can find the annual or quarterly income statement of PMV Pharmaceuticals Inc here for insights into the performance and operational efficiency of PMV Pharmaceuticals Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q1
Operating expenses
-11.80%19.02M
-23.55%19.24M
2.90%22.52M
13.43%22.88M
18.35%21.56M
33.15%25.17M
11.51%21.89M
0.24%20.17M
-15.17%18.22M
-10.68%18.90M
1.31%19.63M
12.51%20.12M
15.37%21.48M
14.56%21.16M
28.34%19.38M
37.05%17.89M
59.49%18.62M
75.91%18.47M
73.51%15.10M
--13.05M
52.52%11.67M
--10.50M
--8.70M
--7.65M
R&D expenses
-12.10%15.33M
14.96%15.83M
7.45%18.21M
25.79%18.40M
32.27%17.44M
2.88%13.77M
24.74%16.95M
5.67%14.63M
-12.52%13.19M
-10.94%13.38M
-0.59%13.59M
20.77%13.84M
27.35%15.07M
23.49%15.03M
49.16%13.67M
49.56%11.46M
57.81%11.84M
96.85%12.17M
52.90%9.16M
--7.66M
25.94%7.50M
--6.18M
--5.99M
--5.96M
Depreciation, depletion, and amortization
-8.11%34.00K
-15.38%33.00K
-91.37%32.00K
-91.40%32.00K
-89.78%37.00K
-89.14%39.00K
3.63%371.00K
0.81%372.00K
111.70%362.00K
378.67%359.00K
383.78%358.00K
350.00%369.00K
103.57%171.00K
-2.60%75.00K
-7.50%74.00K
15.49%82.00K
6.33%84.00K
26.23%77.00K
6.67%80.00K
--71.00K
-15.96%79.00K
--61.00K
--75.00K
--94.00K
Operating profit
11.80%-19.02M
23.55%-19.24M
-2.90%-22.52M
-13.43%-22.88M
-18.35%-21.56M
-33.15%-25.17M
-11.51%-21.89M
-0.24%-20.17M
15.17%-18.22M
10.68%-18.90M
-1.31%-19.63M
-12.51%-20.12M
-15.37%-21.48M
-14.56%-21.16M
-28.34%-19.38M
-37.05%-17.89M
-59.49%-18.62M
-75.91%-18.47M
-73.51%-15.10M
---13.05M
-52.52%-11.67M
---10.50M
---8.70M
---7.65M
Net non-operating interest income (expenses)
Non-operating interest income
-49.35%980.00K
-46.13%1.23M
-43.40%1.48M
-39.66%1.69M
-34.45%1.94M
-27.76%2.29M
-12.37%2.62M
3.89%2.80M
26.97%2.95M
76.18%3.17M
165.48%2.98M
346.36%2.70M
915.28%2.33M
1595.28%1.80M
1001.96%1.12M
434.51%604.00K
78.91%229.00K
120.83%106.00K
155.00%102.00K
--113.00K
-68.47%128.00K
--48.00K
--40.00K
--406.00K
Other non-operating income (expenses)
125.00%1.00K
99.16%-1.00K
-119.01%-23.00K
5.88%-16.00K
-300.00%-4.00K
-466.67%-119.00K
2925.00%121.00K
-183.33%-17.00K
-103.70%-1.00K
-205.00%-21.00K
-69.23%4.00K
80.65%-6.00K
165.85%27.00K
185.71%20.00K
333.33%13.00K
-149.21%-31.00K
21.15%-41.00K
--7.00K
103.00%3.00K
--63.00K
-940.00%-52.00K
--0.00
---100.00K
---5.00K
Income before tax
8.12%-18.04M
21.69%-18.01M
-9.99%-21.07M
-21.97%-21.20M
-28.57%-19.63M
-45.97%-23.00M
-15.10%-19.15M
0.26%-17.39M
20.17%-15.27M
18.55%-15.76M
8.76%-16.64M
-0.69%-17.43M
-3.78%-19.13M
-5.37%-19.34M
-21.65%-18.24M
-34.47%-17.31M
-58.92%-18.43M
-75.63%-18.36M
-71.12%-14.99M
---12.87M
-59.91%-11.60M
---10.45M
---8.76M
---7.25M
Income tax
----
--26.00K
-108.11%-6.00K
100.03%5.00K
---2.20M
100.00%0.00
--74.00K
-404425.00%-16.17M
--0.00
---1.00K
100.00%0.00
300.00%4.00K
-100.00%0.00
--0.00
-147.37%-9.00K
---2.00K
-50.00%2.00K
-100.00%0.00
533.33%19.00K
--0.00
100.00%4.00K
--1.00K
--3.00K
--2.00K
Income after tax
-3.45%-18.04M
21.58%-18.04M
-9.53%-21.06M
-1648.56%-21.21M
-14.18%-17.44M
-45.98%-23.00M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-5.37%-19.34M
-21.44%-18.23M
-34.46%-17.31M
-58.88%-18.43M
-75.62%-18.36M
-71.28%-15.01M
---12.87M
-59.92%-11.60M
---10.45M
---8.76M
---7.25M
Net income from continuous operations
-3.45%-18.04M
21.58%-18.04M
-9.53%-21.06M
-1648.56%-21.21M
-14.18%-17.44M
-45.98%-23.00M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-5.37%-19.34M
-21.44%-18.23M
-34.46%-17.31M
-58.88%-18.43M
-75.62%-18.36M
-71.28%-15.01M
---12.87M
-59.92%-11.60M
---10.45M
---8.76M
---7.25M
Net income attributable to controlling interests
-3.45%-18.04M
21.58%-18.04M
-9.53%-21.06M
-1648.56%-21.21M
-14.18%-17.44M
-45.98%-23.00M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-5.37%-19.34M
-21.44%-18.23M
-34.46%-17.31M
-58.88%-18.43M
-75.62%-18.36M
-71.28%-15.01M
---12.87M
-59.92%-11.60M
---10.45M
---8.76M
---7.25M
Net income attributable to common shareholders
-3.45%-18.04M
21.58%-18.04M
-9.53%-21.06M
-1648.56%-21.21M
-14.18%-17.44M
-45.98%-23.00M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-5.37%-19.34M
-21.44%-18.23M
-34.46%-17.31M
-58.88%-18.43M
-75.62%-18.36M
-71.28%-15.01M
---12.87M
-59.92%-11.60M
---10.45M
---8.76M
---7.25M
Basic earnings per share
-0.77%-0.34
23.62%-0.34
-6.60%-0.40
-1630.90%-0.41
-13.07%-0.34
-44.77%-0.44
-9.88%-0.37
93.81%-0.02
28.97%-0.30
27.56%-0.31
15.09%-0.34
-0.19%-0.38
-3.08%-0.42
-4.65%-0.42
-20.57%-0.40
-32.98%-0.38
-56.50%-0.41
-73.28%-0.40
-69.31%-0.33
---0.29
89.12%-0.26
---0.23
---0.20
---2.38
Diluted earnings per share
-0.77%-0.34
23.62%-0.34
-6.60%-0.40
-1630.90%-0.41
-13.07%-0.34
-44.77%-0.44
-9.88%-0.37
93.81%-0.02
28.97%-0.30
27.56%-0.31
15.09%-0.34
-0.19%-0.38
-3.08%-0.42
-4.65%-0.42
-20.57%-0.40
-32.98%-0.38
-56.50%-0.41
-73.28%-0.40
-69.31%-0.33
---0.29
89.12%-0.26
---0.23
---0.20
---2.38
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read PMV Pharmaceuticals Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing PMVP stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was PMV Pharmaceuticals Inc's net income for the year?

PMV Pharmaceuticals Inc posted -77.74M in net income for fiscal year 2025.

How much net income did PMV Pharmaceuticals Inc post in the last quarter?

PMV Pharmaceuticals Inc reported -18.04M in net income for the latest quarter。

What was PMV Pharmaceuticals Inc's annual operating profit?

PMV Pharmaceuticals Inc's operating income was -86.21M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.